(Q79099941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Molecular diagnostics and personalized medicine. IBC Life Sciences Conference on Pharmacogenomics, June 24-25, 2003, London, UK (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

0 references

0 references

personalized medicine

1 reference

Rhiannon Sanders

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

541-545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

The importance of being modest--reflections on the pharmacogenetics of abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

Individualized cancer therapy: molecular approaches to the prediction of tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.541.23796

10.1517/PHGS.4.5.541.23796

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518454%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference